Publication:
Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study

dc.contributor.authorDANE, FAYSAL
dc.contributor.authorsInal, A.; Isikdogan, A.; Kos, T.; Algin, E.; Gumus, M.; Dikilitas, M.; Elkiran, E. T.; Helvaci, K.; Geredeli, C.; Dane, F.; Balakan, O.; Durnali, A. Gok; Harputluoglu, H.; Goksel, G.; Ozdemir, N.; Buyukberber, S.; Yildiz, R.; Kaplan, M. A.; Ozkan, M.; Uncu, D.
dc.date.accessioned2022-03-10T17:50:52Z
dc.date.accessioned2026-01-11T08:18:22Z
dc.date.available2022-03-10T17:50:52Z
dc.date.issued2011
dc.identifier.doi10.1200/jco.2011.29.15_suppl.e14534
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/221410
dc.identifier.wosWOS:000208880303588
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleGemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume29

Files